Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: A lighthouse and as a toe in the water

EuroIntervention

Volumn 4, Issue , 2008, Pages C39-C44

  Vranckx, Pascal ^a,b   Kint, Peter Paul ^a   Morel, Marie Angele ^a   Van Es, Gerrit Anne ^a   Serruys, Patrick W ^c   Cutlip, Donald E ^d  

^a CARDIALYSIS   (Netherlands)

^b VIRGA JESSE HOSPITAL   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CLINICAL EFFECTIVENESS; CONSENSUS DEVELOPMENT; CORONARY ANGIOGRAPHY; HEALTH CARE ORGANIZATION; HEART DEATH; HEART INFARCTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; REVASCULARIZATION; ST SEGMENT ELEVATION; STENT THROMBOSIS; CONSENSUS; CORONARY ARTERY THROMBOSIS; DEATH; DRUG ELUTING STENT; INCIDENCE; METHODOLOGY; PATHOLOGY; RESEARCH; STATISTICS; THROMBECTOMY; THROMBOCYTE;

PACLITAXEL;

BLOOD PLATELETS; CONSENSUS; CORONARY THROMBOSIS; DEATH; DRUG-ELUTING STENTS; HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; PACLITAXEL; RESEARCH; THROMBECTOMY;

EID: 63149125564     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Curfman GD, Morrissey S, Jarcho JA, Drazen JM. Drug-Eluting Coronary Stents-Promise and Uncertainty. N Engl J Med. 2007 Mar 8;356(10): 1059-60.
2. Maisel WH. Unanswered questions. Drug-Eluting stents and the risks of late thrombosis. N Engl J Med 2007, 356: 981-984.
3. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356: 1009-1019.
4. Farb A, Boam AB. Stent Thrombosis Redux-The FDA perspective. N Engl J Med 2007; 356: 984-287.
5. Shuchman M. Debating the risks of drug-eluting stents. N Engl J Med 2007;356: 325-328.
6. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky AJ, Hamon M, Krucoff MW, Serruys P. Clinical endpoints in coronary stent trials. Circulation. 2007; 115: 2344-2351
7. Capone G, Wolf NM, Meyer B, Meister SG. Frequency of intracoronary filling defects by angiography in angina pectoris at rest. Am J Cardiol 1985; 56: 403-6.
8. Thygesen K, Alpert JS, White HD on behalf of the joint ESC/ACCF/ AHA/WHF task force for the redefinition of myocardial infaction. Eur Heart J 2007, 28: 2525-2538.
9. Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Mehran R, Na Y, Turco M, Caputo R, Popma JJ, Cutlip DE, Russell ME, Cohen DJ; TAXUS-IV Investigators. TAXUS-IV Investigators. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: Results from the TAXUS-IV trial. J Am Coll Cardiol. 2006, 48(1): 32-6.
10. Garot P, Lefèvre T, Savage M, Louvard Y, Bamlet WR, Willerson JT, Morice MC, Holmes DR Jr. Nine month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era. A report from the prevention with tranilast and it outcomes (Presto) trial. J Am Coll Cardiol 2005; 46: 606-612.
11. Tsuchida K, Colombo A, Lefèvre T, Oldroyd KG, Guetta V, Guagliumi G, von Scheidt W, Ruzyllo W, Hamm CW, Bressers M, Stoll HP, Wittebols K, Donohoe DJ, Serruys PW. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimuseluting stent: Insights from the arterial revascularisation therapies study part II (ARTS II). European Heart Journal 2007, 28: 433-442.
12. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Tahk SJ. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005; 46: 633-637.
13. Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT II). Lancet 1998; 352: 673-681.
14. Serruys PW, Daemen J, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins KD, Vranckx P, Bressers M, van Domburg R, Schuijer M, Wittebols K, Pieters M, Stoll HP on behalf of the ARTS-II Investigators. Three-year follow-up of the ARTS-II -sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroInterv.2007;3: 450-459.
15. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006;151: 1260-4.